Cipla stake sale plan faces hurdle as promoters differ on valuation: Report

Cipla's potential stake sale faces a challenge due to disagreements among its promoters regarding the company's valuation. This dispute among the founders could potentially delay the deal until a consensus is reached on the valuation, according to sources cited by ET Now.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/zK1uwhL
via IFTTT